What is H.C. Wainwright's price target for ORIC?

H.C. Wainwright's latest stated price target for Oric Pharmaceuticals Inc. (ORIC) is $16, from its action on Mar 23, 2023.

What is H.C. Wainwright's rating on ORIC?

H.C. Wainwright rates ORIC Buy, a bullish rating, as of Mar 23, 2023.

When did H.C. Wainwright last change its view on ORIC?

On Mar 23, 2023, H.C. Wainwright upgrades to Buy from Neutral, price target $16.

Analyst firms · H.C. Wainwright · ORIC

H.C. Wainwright ORIC price target and rating history

Oric Pharmaceuticals Inc. (ORIC) · Health Care

H.C. Wainwright rates Oric Pharmaceuticals Inc. (ORIC) Buy with a $16 price target, as of its latest action on Mar 23, 2023. It has published 5 rating actions on ORIC since August 2021, including 1 upgrade and 1 downgrade. Across 6 firms with a ORIC price target in the last 12 months, the median target is $23.50.

Current rating: Buy
Price target: $16
Median target, all firms: $23.50
Actions on ORIC: 5

H.C. Wainwright price target on ORIC

H.C. Wainwright price target on ORIC, each point a stated target, August 2021 to March 2023.

Every H.C. Wainwright rating on ORIC

Mar 23, 2023
UpgradeH.C. Wainwright upgrades to Buy from Neutral, price target $16
Mar 25, 2022
DowngradeH.C. Wainwright downgrades to Neutral from Buy
Nov 10, 2021
ReiterateH.C. Wainwright raises its price target to $31 from $30, keeps Buy
Oct 8, 2021
ReiterateH.C. Wainwright cuts its price target to $30 from $53, keeps Buy
Aug 11, 2021
ReiterateH.C. Wainwright cuts its price target to $53 from $54, keeps Buy

How other firms rate ORIC

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Leerink Partners	Outperform	$26	Oct 5, 2026
BTIG	Buy	$26	Sep 23, 2026
Stifel	Buy	$14	Jun 12, 2026
Goldman Sachs	Buy	$15	May 15, 2026
Piper Sandler	Overweight	$22	Jan 7, 2026
Evercore ISI	Outperform	$25	Nov 20, 2025
Wolfe Research	Peer Perform		Nov 18, 2025

Questions about H.C. Wainwright and ORIC

What is H.C. Wainwright's price target for ORIC?: H.C. Wainwright's latest stated price target for Oric Pharmaceuticals Inc. (ORIC) is $16, from its action on Mar 23, 2023.
What is H.C. Wainwright's rating on ORIC?: H.C. Wainwright rates ORIC Buy, a bullish rating, as of Mar 23, 2023.
When did H.C. Wainwright last change its view on ORIC?: On Mar 23, 2023, H.C. Wainwright upgrades to Buy from Neutral, price target $16.
How does H.C. Wainwright's ORIC target compare with other analysts?: Across 6 firms with a ORIC price target in the last 12 months, the median target is $23.50.

More ORIC rating histories

All H.C. Wainwright ratings ORIC news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.